Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Doximity, Inc. Class A Common Stock (NY: DOCS )

77.07 +0.08 (+0.10%)
Official Closing Price Updated: 7:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Doximity, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Investors seeking growth at a reasonable cost should explore NYSE:DOCS.
Uncover the potential of DOXIMITY INC-CLASS A, a growth stock reasonably priced. NYSE:DOCS is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive... 
Via Chartmill
Reasonable Growth, Debt Levels, and a High ROIC Make DOXIMITY INC-CLASS A (NYSE:DOCS) Appealing to Quality Investors.
Why Quality-Oriented Investors Should Consider NYSE:DOCS. 
Via Chartmill
Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025
From Doximity
Via Business Wire
Spotting Winners: Doximity (NYSE:DOCS) And Vertical Software Stocks In Q3
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at vertical software stocks, starting with... 
Via StockStory
Demystifying Doximity: Insights From 15 Analyst Reviews
Via Benzinga
Looking Into Doximity's Recent Short Interest
Via Benzinga
NYSE:DOCS—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
DOXIMITY INC-CLASS A (NYSE:DOCS)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
Why the quality investor may take a look at DOXIMITY INC-CLASS A (NYSE:DOCS).
Why DOXIMITY INC-CLASS A (NYSE:DOCS) qualifies as a quality stock. 
Via Chartmill
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
The top-performing stocks last week were TEVA, KVYO, DRI, DOCS, BIRK, JBL, NBIX, GME, RDY, and LI. Did you have any of them in your portfolio? 
Via Benzinga
Kick-Save And A Beauty; Two New Swing Positions
In this video, I review the overall market. I also provide two new swing positions, along with my exact game plan for Monday's session. 
Via Talk Markets
Topics ETFs Stocks / Equities
Google Leads Five Stocks Near Buy Points, Standing Tall In Tricky Market
The AI giant leads stocks near buy points as the postelection rally turns volatile. 
Via Investor's Business Daily
Topics Artificial Intelligence
Exposures Artificial Intelligence
Forecasting The Future: 15 Analyst Projections For Doximity
Via Benzinga
(DOCS) - Analyzing Doximity's Short Interest
Via Benzinga
Analyst Ratings For Doximity
Via Benzinga
Is NYSE:DOCS suited for quality investing?
This article explores why quality investors may have a look at DOXIMITY INC-CLASS A (NYSE:DOCS) 
Via Chartmill
NYSE:DOCS: a strong growth stock preparing for the next leg up?.
DOXIMITY INC-CLASS A (NYSE:DOCS)—Positioned as a High-Growth Stock, Ready for a Potential Breakout. 
Via Chartmill
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Veeva Systems Stock Sees IBD RS Rating Improve To 72
Veeva Systems stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 68 to 72. 
Via Investor's Business Daily
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care
From Doximity
Via Business Wire
Earnings To Watch: Veeva Systems (VEEV) Reports Q3 Results Tomorrow
Healthcare software provider Veeva Systems (NASDAQ:VEEV) will be reporting earnings tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Is NYSE:DOCS a Suitable Choice for Quality Investing?
This article explores why quality investors may have a look at DOXIMITY INC-CLASS A (NYSE:DOCS) 
Via Chartmill
Two Reasons to Like DOCS and One to Stay Skeptical
Doximity has been on fire lately. In the past six months alone, the company’s stock price has rocketed 86.8%, reaching $53.60 per share. This was partly due to its solid quarterly results, and the... 
Via StockStory
3 Chart Patterns That Cut Through The Market’s Chaos
There are endless ways of analyzing price data. But the truth is, I don’t use 90% of it. What I find most useful when analyzing stock charts is pattern recognition. Today, I’ll review three of the... 
Via Talk Markets
This Campbell Soup Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
This Caterpillar Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Donald Trump Victory Week (Nov 4-8): These Large Cap Stocks Were Biggest Gainers
Top-performing large-cap stocks last week: APP (+82.27%), TEM (+49.03%), COIN (+45.35%), ALAB (+42.57%), PLTR (+41.0%), AXON (+39.76%), DOCS (+39.29%), TSLA (+32.28%), HOOD (+25.58%), RDDT (+23.64%). 
Via Benzinga
Topics Government
Exposures Political
Masters In Trading - Saturday, Nov. 9
In this video, I discuss recent earnings and review some trades taken throughout the past week. 
Via Talk Markets
Why Doximity Stock Is Skyrocketing Today
The market loved what it saw from Doximity's second-quarter earnings. 
Via The Motley Fool
Doximity (DOCS) Stock Trades Up, Here Is Why
Shares of healthcare professional network Doximity (NYSE:DOCS) jumped 48.2% in the afternoon session after the company reported impressive third-quarter earnings, which blew past analysts' revenue,... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.